Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

Forgot your password?

Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

I agree to TheMaven'sTerms andPolicy

Already have an account? Login here

JIM CRAMER INVESTING PERSONAL FINANCE RETIREMENT TECHNOLOGY MARKETS HOW-TO VIDEO FINANCIAL ADVISOR CENTER

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

Precipio Signs Sales & Marketing Agreement For HemeScreen™ With Major Oncology Distributor

By GlobeNewswire
Dec 10, 2020 10:15 AM EST

Precipio Announces Q3-2020 Shareholder Update Call

By GlobeNewswire
Nov 11, 2020 9:00 AM EST

Precipio & ADS Biotec Launch Seven Beta Sites For IV-Cell™

By GlobeNewswire
Oct 6, 2020 10:00 AM EDT

Precipio Launches Its Proprietary HemeScreen™ AML (Acute Myeloid Leukemia) Molecular Panel

By GlobeNewswire
Sep 22, 2020 10:30 AM EDT

Precipio Announces A Shareholder Call To Discuss Its COVID-19 Progress And Future Plans

By GlobeNewswire
Sep 4, 2020 9:00 AM EDT

Precipio & ADS Biotec Sign Global Distribution Agreement For IV-Cell™

By GlobeNewswire
Aug 20, 2020 1:00 PM EDT

Precipio Announces Q2-2020 Corporate Update Call For Shareholders

By GlobeNewswire
Aug 7, 2020 9:00 AM EDT

Precipio Launches Covid-19 Antibody Test In Its CLIA Laboratory

By GlobeNewswire
Aug 4, 2020 10:45 AM EDT

Precipio Announces Commercial Launch Of COVID-19 Antibody Test

By GlobeNewswire
Jul 30, 2020 10:15 AM EDT

Precipio Regains Listing Compliance With NASDAQ Minimum Bid Requirement

By GlobeNewswire
Jul 1, 2020 2:00 PM EDT

Precipio Adds Another HemeScreen™ Customer

By GlobeNewswire
Jun 9, 2020 10:00 AM EDT

Precipio Announces Q1-2020 Corporate Update Call For Shareholders

By GlobeNewswire
May 12, 2020 5:00 PM EDT

Precipio Launches New HemeScreen™ Reagent Rental Program

By GlobeNewswire
Apr 6, 2020 10:00 AM EDT

Company Update During The COVID-19 Era

By GlobeNewswire
Mar 20, 2020 9:30 AM EDT

Precipio Completes The Transaction With Poplar Healthcare's Oncometrix Hematopathology Division

By GlobeNewswire
Mar 16, 2020 9:30 AM EDT

Precipio Achieves Impressive Initial Results Of Artificial Intelligence Decision-Support Tool

By GlobeNewswire
Feb 26, 2020 11:30 AM EST

Precipio In Advanced Discussions With Poplar Healthcare Towards A Multi-faceted Strategic Partnership

By GlobeNewswire
Feb 18, 2020 10:00 AM EST

TrialJectory And Precipio Partner To Provide Cancer Patients With First-of-its-Kind Diagnostic And Clinical Trial-Matching Service

By PR Newswire
Jan 28, 2020 9:00 AM EST

Precipio Provides Clarification To Amendment No.1 To Form S-1 Filing

By GlobeNewswire
Jan 28, 2020 7:30 AM EST

Precipio Provides Clarification To Recent S-1 Filing

By GlobeNewswire
Jan 15, 2020 7:30 AM EST

Precipio Announces Shareholder Update Call To Kick Off 2020

By GlobeNewswire
Jan 13, 2020 5:00 PM EST

Terms Of Use
Privacy Policy
Advertise
Reprints
Customer Service
Data
Topic Archive
Subscriptions

© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.